Pfizer's Dividend Yield: A Bold Hunter's Path

This episode discusses Pfizer's current stock performance and pharmaceutical pipeline. It highlights the company's track record, recent acquisitions, and new treatments, suggesting it as an attractive option for income-seeking investors due to its dividend yield.

Listen